Log In
Print
BCIQ
Print
Print this Print this
 

SHP602 (formerly FBS0701, SPD 602)

  Manage Alerts
Collapse Summary General Information
Company Shire plc
DescriptionMetal chelator
Molecular Target
Mechanism of ActionChelating agent
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard Indication Hematology (unspecified)
Indication DetailsTreat chronic iron overload; Treat transfusional iron overload
Regulatory Designation U.S. - Orphan Drug (Treat chronic iron overload);
EU - Orphan Drug (Treat chronic iron overload)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$319.5M

$94.5M

$225.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today